Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

Journal of Hepatology

Volumn 41, Issue 1, 2004, Pages 19-24

  Yokoyama, Hirokazu ^a   Hirose, Hiroshi ^a   Ohgo, Hideki ^a   Saito, Ikuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adiponectin; Fatty liver; Insulin resistance

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CHOLESTEROL; GUANOSINE TRIPHOSPHATE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; HYPOLIPEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FATTY LIVER; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 3442884807     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.03.003     Document Type: Article

References (26)

1. Ferrannini E. Syndrome X. Horm Res. 39:1993;107-111
2. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37:2003;917-923
3. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 11:2000;327-332
4. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo). 120:1996;803-812
5. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 221:1996;286-289
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257:1999;79-83
7. Hotta K., Funakoshi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansesn B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 50:2001;1126-1133
8. Matsubara M., Maruoka S., Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 87:2002;2764-2769
9. Harrison S.A., Kadakia S., Lang K.A., Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol. 97:2002;2714-2724
10. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 7:2001;947-953
11. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 108:2001;1875-1881
12. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 8:2002;1288-1295
13. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423:2003;762-769
14. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 112:2003;91-100
15. deLabry L.O., Glynn R.J., Levenson M.R., Hermos J.A., LoCastro J.S., Vokonas P.S. Alcohol consumption and mortality in an American male population: recovering the U-shaped curve - findings from the normative aging study. J Stud Alcohol. 53:1992;25-32
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
17. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 148:2003;293-300
18. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Colch). 103:2002;137-142
19. Day C.P. Pathogenesis of steatohepatitis. Baillieres Best Pract Res Clin Gastroenterol. 16:2002;663-678
20. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA. 94:1997;2557-2562
21. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 96:2000;1723-1732
22. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102:2000;1296-1301
23. Steppan C.M., Lazar M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 13:2002;18-23
24. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res. 10:2002;1104-1110
25. Combs T.P., Wagner J.A., Berger J., Doebber T., Wang W.J., Zhang B.B., et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 143:2002;998-1007
26. Hirose H., Kawai T., Yamamoto Y., Taniyama M., Tomita M., Matsubara K., et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism. 51:2002;314-317